Agomab Therapeutics NV (AGMB): SCHEDULE 13G filed Apr 16, 2026

Form type

SCHEDULE 13G

Filing date

Apr 16, 2026

Accession number

0001213900-26-044365

Filer

Agomab Therapeutics NV (CIK 2020932)